Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
RCVi / BravoVax
NCT05706324: Phase Ⅰ Clinical Trial of a Candidate COVID-19 Vaccine	Not yet recruiting	1	60	RoW	Recombinant COVID-19 Vaccine (chimpanzee adenovirus vector) for Inhalation, RCVi	Wuhan BravoVax Co., Ltd., National University Hospital, Singapore, Shanghai BravoBio Co., Ltd.	COVID-19	12/23	07/24
NCT06721065: A Study of Language Interpretation Solutions for People With Breast Cancer	Recruiting	N/A	640	US	Remote Simultaneous Medical Interpreting/RSMI, Remote Consecutive Medical Interpreting/RCMI, Remote Consecutive Video Medical Interpreting/RCVI	Memorial Sloan Kettering Cancer Center	Breast Cancer, Breast Cancer Stage II, Breast Cancer Stage III	12/29	12/29